At Singapore’s gleaming Biopolis complex, researchers get all the money and lab support they need. What they don’t get is time.
Could “medical homes,” where every patient has a physician-led support team, improve health and reduce costs? Early evidence says yes.
The protein endothelin shows up everywhere, so scientists hoped blocking its action could treat many diseases. It hasn’t happened—yet.
When the retina fails, the body’s window on the world slams shut. These futuristic treatments may pry it open again.
Peter L. Slavin and David F. Torchiana sound off on the potential of health care reform.
Readers share their take on criticizing physicians, genetic testing, and cancer’s deadly spread.
An underdiagnosed condition gets its first new drug in 40 years.
Each year, several thousand people die waiting for a kidney transplant. Could a new strategy that relies on altruistic donors help reduce that number?
Rita Charon, director of a new program in narrative medicine at Columbia University, discusses how developing narrative skills can create better physicians.
Americans spent $6.7 billion on mouth-freshening products in 2007, but popping a mint or gargling green stuff is no match for hardcore halitosis.
Fifty years ago, a landmark paper by William B. Kouwenhovendescribed a lifesaving technique that would come to be known as CPR—and lead to the development of the first closed-chest defibrillator.
A movement to ban uncredited contributors is growing among medical journals.
Handouts from drug companies might seem helpful, but some experts contend that they create conflicts of interest and raise prescription costs.
Public health messages reach remote areas in a musical manner.
For one mother, getting her thyroid under control could also mean forgoing a second child.